HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
DividendPress.com is following several dividend stocks including MPW, BANF, AVGO and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Gilead Sciences
Symbol: GILD
Recent GILD Price: $88.54
Average Analyst Price Target: $84.61 (-4.44%)
GILD Market Cap: $110.34B
Expected Ex-Dividend Date for GILD stock: Dec 14 2022
Expected Payment Date for GILD stock: Dec 29 2022
Expected Dividend & Yield for GILD stock: 3.24%
Recent Analyst Action: Elmar Kraus, analyst at DZ BANK AG, reiterates coverage on Gilead Sciences (GILD) stock in the Healthcare sector with a Hold rating and a price target of $ 90 (3 days ago).
Click for full story on GILD stock >>--------------------------------------------------------------------------
Merck & Company
Symbol: MRK
Recent MRK Price: $108.97
Average Analyst Price Target: $110.27 (1.19%)
MRK Market Cap: $275.80B
Expected Ex-Dividend Date for MRK stock: Dec 14 2022
Expected Payment Date for MRK stock: Jan 09 2023
Expected Dividend & Yield for MRK stock: 2.54%
Recent Analyst Action: Geoff Meacham, analyst at Bank of America Securities, reiterates coverage on Merck & Company (MRK) stock in the Healthcare sector with a Hold rating and a price target of $ 110 (23 hours ago).
Click for full story on MRK stock >>--------------------------------------------------------------------------
Thermo Fisher
Symbol: TMO
Recent TMO Price: $567.6
Average Analyst Price Target: $618.43 (8.96%)
TMO Market Cap: $219.72B
Expected Ex-Dividend Date for TMO stock: Dec 14 2022
Expected Payment Date for TMO stock: Jan 16 2023
Expected Dividend & Yield for TMO stock: 0.20%
Recent Analyst Action: Conor McNamara, analyst at RBC Capital, reiterates coverage on Thermo Fisher (TMO) stock in the Healthcare sector with a Buy rating and a price target of $ 661 (6 days ago).
Click for full story on TMO stock >>--------------------------------------------------------------------------
DividendPress.com helps you find the best performing dividend stocks. We alert our subscribers of coming ex-dividend dates.
